Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

7.66
-0.0900-1.16%
Post-market: 7.65-0.0099-0.13%19:44 EDT
Volume:944.02K
Turnover:7.29M
Market Cap:1.05B
PE:191.50
High:7.85
Open:7.72
Low:7.65
Close:7.75
Loading ...

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event

TIPRANKS
·
27 Feb

Aurinia: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $0.01, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals Q4 2024 GAAP EPS $0.01 Beats $(0.02) Estimate, Sales $59.87M Miss $59.94M Estimate

Benzinga
·
27 Feb

BRIEF-Aurinia Pharmaceuticals Q4 Pretax Profit USD 1.173 Million

Reuters
·
27 Feb

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

THOMSON REUTERS
·
27 Feb

Aurinia Pharmaceuticals Q4 Operating Expenses USD 61.536 Million

THOMSON REUTERS
·
27 Feb

Aurinia Pharmaceuticals Inc: Outlook FY Net Product Sales in Range of $240 Mln to $250 Mln

THOMSON REUTERS
·
27 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Feb

High Growth Tech Stocks In The United States Spotlighting Three Leaders

Simply Wall St.
·
26 Feb

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now?

Insider Monkey
·
26 Feb

Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
25 Feb

Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
11 Feb

Corcept (CORT) Soars 13.6%: Is Further Upside Left in the Stock?

Zacks
·
31 Jan

Aurinia (AUPH) Upgraded to Buy: Here's Why

Zacks
·
23 Jan

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.
·
12 Dec 2024

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Zacks
·
10 Dec 2024

While institutions own 40% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), retail investors are its largest shareholders with 52% ownership

Simply Wall St.
·
06 Dec 2024

We Might See A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Soon

Simply Wall St.
·
03 Dec 2024

Positive Outlook for Aurinia Pharmaceuticals Boosted by Favorable Lupus Nephritis Guidelines

TIPRANKS
·
21 Nov 2024